GlassScriptPhysician profile
Kristi A Kerner
NPI 1992787964
$3,818.87
in general payments reported to CMS, 2019-2025
41 companies · $264 in 2025
The $264 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $88.36 · 2020: $493 · 2021: $636 · 2022: $1,032 · 2023: $1,004 · 2024: $301 · 2025: $264.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,569.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,569.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $843.21 | 2020-2025 | |
| Amgen INC. | $601.60 | 2019-2024 | Evenity, Prolia, Repatha |
| Novo Nordisk INC | $366.37 | 2020-2025 | Ozempic, Rybelsus, Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $234.49 | 2020-2025 | Jardiance, Ofev |
| Glaxosmithkline, LLC. | $185.26 | 2019-2025 | Trelegy Ellipta, Nucala |
| Pfizer INC. | $151.56 | 2021-2025 | |
| Lilly USA, LLC | $144.81 | 2021-2023 | Zepbound |
| Allergan, INC. | $135.26 | 2020 | |
| Teva Pharmaceuticals USA, INC. | $100.40 | 2020-2022 | |
| Vanda Pharmaceuticals INC. | $99.76 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $74.08 | 2022-2023 | Xifaxan |
| Astellas Pharma US INC | $67.63 | 2021-2025 | Veozah |
| Novartis Pharmaceuticals Corporation | $62.76 | 2022 | |
| Harmony Biosciences LLC | $54.77 | 2021 | |
| Jazz Pharmaceuticals INC. | $49.91 | 2021-2022 |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kristi Kerner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.